Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00034866
Status:
COMPLETED
Last Update Posted:
2005-09-20
First Post:
2002-05-02
Brief Title:
Dose Ranging Trial of TipranavirRitonavir in Treatment-Experienced HIV Infected Individuals
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim